Is this you?
Request access for Centricity Research with your @centricityresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Centricity Research
Unclaimed profileSite Network · Columbus, GA (US HQ); Toronto (Canada HQ) · ~35+ sites
Intera lens
ICP 8Lift (cardio sample) 0.00Recruit soph 1
Quality Scorecard (1–100)
Overall75Recruit96Ops65Sponsor71Ther66
Performance (observed)
Historical trials
245
Completed
95
Terminated/Withdrawn
23
Completion rate
81%
Active now
125
Phase 2
74
Phase 3
144
Realized enrollment
574,620
First study year
2018
Years active
8
Match confidence
high
Enrollment velocity (inf)
71,828
Therapeutic
Areas
35+ therapeutic areas including infectious disease, neurology, endocrinology, oncology, cardiology, dermatology, women's health, vaccines, gastroenterology
Specialties
35+ therapeutic areas; oncology, cardiology, endocrinology, infectious diseases, and more
Breadth (conditions)
200
Languages
English + Spanish (detected)
States
GA, OH, VA, NC, and others across US/Canada
Recruitment (web observed)
Meta Pixel
Yes
Facebook Ads
Yes
Google Ads
Yes
Trial Finder
Yes
Patient database
Y; 7.8 million patient database
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong; 3500+ studies completed, 100+ FDA/Health Canada approvals
Capability notes
7.8M+ patient access; 150+ active investigators; 3,500+ studies completed; 25,000+ patients served; IRO model with inpatient/outpatient capabilities
Relationships
Sponsors
Novo Nordisk A/S; Pfizer; Eli Lilly and Company; ModernaTX, Inc.; AbbVie; Amgen
CROs
Calian CRO; ICON plc; IQVIA Pty Ltd; PPD Development, LP; Parexel; Syneos Health
Owner / parent
Trinity Hunt Partners, LP (private equity)
Acquisitions
Lucas Research (North Carolina) acquired
Expansion
Lucas Research acquisition (North Carolina); multi-state network; 25,000+ patients served
Recent hiring
Y; active recruitment across U.S. and Canada
Capacity & people
Investigators
—
Coordinators
—
CEO
Will Furness
VP Clinical Ops
Amanda Phillips (VP Clinical Operations)
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown
Tech & DCT
eSource
Yes
eConsent
Yes
Builds tech
Unknown
DCT / decentralized
Y; expanding network reach
Tech stack
Unknown
Recruiting visible
Y
Notes
Strong Intera fit: 35+ sites, 7.8M patient access, 150+ investigators, PE-backed (growth-focused), broad therapeutic mix, multiple concurrent studies. Largest clinical research networks in North America. 2021 merger (IACT + LMC Manna) shows roll-up strategy. Strong operational foundation with clear recruitment demand. [Validated: 4 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 0.35Liftability 0.00Overall75
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.